FDA has acknowledged that, under former commissioner von Eschenbach, it may have been influenced by the "extreme" and "persistent" pressure applied by four congressmen in approving the Menaflex knee patch. The New York Times goes into more detail:
The agency has never before publicly questioned the process behind one of its approvals, never admitted that a regulatory decision was influenced by politics, and never accused a former commissioner of questionable conduct.
Is admitting the sins of the past part of the transparency that FDA commissioner Hamburg has promised?
--PWT
